These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8127052)

  • 21. Four novel mutations underlying mild or intermediate forms of alpha-L-iduronidase deficiency (MPS IS and MPS IH/S).
    Tieu PT; Bach G; Matynia A; Hwang M; Neufeld EF
    Hum Mutat; 1995; 6(1):55-9. PubMed ID: 7550232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hurler syndrome: early diagnosis and treatment].
    Leroux S; Muller JB; Boutaric E; Busnel A; Lemouel F; Andro-Garçon M; Neven B; Valayannopoulos V; Vinceslas C
    Arch Pediatr; 2014 May; 21(5):501-6. PubMed ID: 24698225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The alpha-L-iduronidase mutations R89Q and R89W result in an attenuated mucopolysaccharidosis type I clinical presentation.
    Hein LK; Hopwood JJ; Clements PR; Brooks DA
    Biochim Biophys Acta; 2003 Oct; 1639(2):95-103. PubMed ID: 14559116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucopolysaccharidosis type I: identification of 8 novel mutations and determination of the frequency of the two common alpha-L-iduronidase mutations (W402X and Q70X) among European patients.
    Bunge S; Kleijer WJ; Steglich C; Beck M; Zuther C; Morris CP; Schwinger E; Hopwood JJ; Scott HS; Gal A
    Hum Mol Genet; 1994 Jun; 3(6):861-6. PubMed ID: 7951228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucopolysaccharidosis type I: characterization of a common mutation that causes Hurler syndrome in Moroccan subjects.
    Alif N; Hess K; Straczek J; Sebbar S; N'Bou A; Nabet P; Dousset B
    Ann Hum Genet; 1999 Jan; 63(Pt 1):9-16. PubMed ID: 10738517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hurler syndrome with severe complication in post-bone marrow transplantation course: life threatening interstitial pneumonitis and hypertension.
    Ohashi T; Tahara T; Fujisawa K; Hoshi Y; Ito F; Suzuki N; Eto Y; Maekawa K
    Acta Paediatr Jpn; 1995 Dec; 37(6):697-700. PubMed ID: 8775554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mutation analysis and prenatal diagnosis of 2 cases with mucopolysaccharidosis type I].
    Wang XN; Wei M; Shi HP; Qiu ZQ; Yao FX; Meng Y; Zhang WM
    Zhonghua Er Ke Za Zhi; 2011 Apr; 49(4):306-10. PubMed ID: 21624210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and characterization of 20 novel pathogenic variants in 60 unrelated Indian patients with mucopolysaccharidoses type I and type II.
    Uttarilli A; Ranganath P; Matta D; Md Nurul Jain J; Prasad K; Babu AS; Girisha KM; Verma IC; Phadke SR; Mandal K; Puri RD; Aggarwal S; Danda S; Sankar VH; Kapoor S; Bhat M; Gowrishankar K; Hasan AQ; Nair M; Nampoothiri S; Dalal A
    Clin Genet; 2016 Dec; 90(6):496-508. PubMed ID: 27146977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laronidase for cardiopulmonary disease in Hurler syndrome 12 years after bone marrow transplantation.
    Valayannopoulos V; de Blic J; Mahlaoui N; Stos B; Jaubert F; Bonnet D; Fischer A; de Lonlay P
    Pediatrics; 2010 Nov; 126(5):e1242-7. PubMed ID: 20974778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term outcome of Hurler syndrome following bone marrow transplantation.
    Whitley CB; Belani KG; Chang PN; Summers CG; Blazar BR; Tsai MY; Latchaw RE; Ramsay NK; Kersey JH
    Am J Med Genet; 1993 Apr; 46(2):209-18. PubMed ID: 8484412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful treatment of severe heart failure in an infant with Hurler syndrome.
    Hirth A; Berg A; Greve G
    J Inherit Metab Dis; 2007 Oct; 30(5):820. PubMed ID: 17768668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular analysis of 30 mucopolysaccharidosis type I patients: evaluation of the mutational spectrum in Italian population and identification of 13 novel mutations.
    Venturi N; Rovelli A; Parini R; Menni F; Brambillasca F; Bertagnolio F; Uziel G; Gatti R; Filocamo M; Donati MA; Biondi A; Goldwurm S
    Hum Mutat; 2002 Sep; 20(3):231. PubMed ID: 12203999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Mutation analysis of 11 Chinese patients with attenuated mucopolysaccharidosis type].
    WANG XN; SHI HP; ZHANG WM; QIU ZQ; MENG Y; YAO FX; WEI M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Apr; 28(2):147-51. PubMed ID: 21462124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ocular abnormalities in the mucopolysaccharidoses after bone marrow transplantation. Longer follow-up.
    Gullingsrud EO; Krivit W; Summers CG
    Ophthalmology; 1998 Jun; 105(6):1099-105. PubMed ID: 9627663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genotype-phenotype correlations in mucopolysaccharidosis type I using enzyme kinetics, immunoquantification and in vitro turnover studies.
    Bunge S; Clements PR; Byers S; Kleijer WJ; Brooks DA; Hopwood JJ
    Biochim Biophys Acta; 1998 Sep; 1407(3):249-56. PubMed ID: 9748610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mucopolysaccharidosis type I: identification of alpha-L-iduronidase mutations in Tunisian families].
    Chkioua L; Khedhiri S; Jaidane Z; Ferchichi S; Habib S; Froissart R; Bonnet V; Chaabouni M; Dandana A; Jrad T; Limem H; Maire I; Abdelhedi M; Laradi S
    Arch Pediatr; 2007 Oct; 14(10):1183-9. PubMed ID: 17728118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutational and oxidative stress analysis in patients with mucopolysaccharidosis type I undergoing enzyme replacement therapy.
    Pereira VG; Martins AM; Micheletti C; D'Almeida V
    Clin Chim Acta; 2008 Jan; 387(1-2):75-9. PubMed ID: 17920576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IDUA mutational profile and genotype-phenotype relationships in UK patients with Mucopolysaccharidosis Type I.
    Ghosh A; Mercer J; Mackinnon S; Yue WW; Church H; Beesley CE; Broomfield A; Jones SA; Tylee K
    Hum Mutat; 2017 Nov; 38(11):1555-1568. PubMed ID: 28752568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates.
    Sands MS; Barker JE; Vogler C; Levy B; Gwynn B; Galvin N; Sly WS; Birkenmeier E
    Lab Invest; 1993 Jun; 68(6):676-86. PubMed ID: 8515654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucopolysaccharidosis type I: clinical and biochemical study.
    Bassyouni HT; Afifi HH; el-Awadi MK; Meguid NA
    East Mediterr Health J; 2000; 6(2-3):359-66. PubMed ID: 11556024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.